Real‐life experience of upadacitinib for the treatment of adult patients with moderate‐to‐severe atopic dermatitis – a case series. (21st June 2022) - Feraru, G.; Nevet, M.J.; Samuelov, L.; Hodak, E.; Avitan‐Hersh, E.; Ziv, M.; Dodiuk‐Gad, R.P.